The job market continued to improve in December, but a stagnating labor pool will pose more challenges for employers in 2022.
Academic rigour, journalistic flair
Articles on Omicron variant
Displaying 101 - 120 of 151 articles
Here’s what we know so far.
A nationwide genomic surveillance system analyzes positive COVID-19 tests to build a picture of which variants are spreading in the population.
A dispute between the Chicago Teachers Union and the school district over in-person learning has resulted in classes being canceled. An education policy expert explains what is at stake.
The South African government has chosen a pragmatic approach that balances the potential direct and detrimental indirect effects of Covid.
Even minor reductions in COVID transmission rates due to early isolation would justify the additional costs associated with the policy.
Will we now see a proper pandemic recovery?
The prime minister’s inflexibility on the home-testing COVID tests is beyond curious - especially in an election year.
Is South Africa a good comparator for how omicron will play out in the UK?
By prioritising prudence over business support, the chancellor will probably do more harm in the long run.
The Biden administration intends to distribute an additional 500 million at-home rapid COVID tests starting in January.
New omicron cases are doubling approximately every two days in some parts of the UK, including London.
Some vaccine hesitancy is based on a fear of the nanoparticles used in mRNA vaccines. But humans have been interacting with nanoparticles for millennia, and we use nanotechnology-based devices every day.
Fewer people in deprived areas have been receiving the COVID booster shots.
DNA sequencing has allowed researchers to catch new COVID-19 variants hours after receiving the first positive test sample.
A panel of experts answer questions about vaccines, omicron and other COVID-related issues in a discussion with The Conversation.
The public has been asked to cut back on socialising ahead of Christmas – but does this request go far enough?
For a number of reasons, as time goes on vaccines become less effective. So how do researchers calculate how well vaccines are working?
The revolt over new restrictions comes in stark contrast to support of other draconian laws.
In places with low vaccination rates, COVID-19 has the chance to linger, and variants develop and travel. Without global vaccine equity, this entirely predictable pattern will repeat itself.
Top contributors
-
Professorial Fellow, University of Canberra
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Associate Professor of Molecular Medicine, UMass Chan Medical School
-
Professor, Infectious Diseases and Microbiology, The University of Queensland
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Medicine, University of East Anglia
-
Professor and Department Chair of Infectious Diseases and Microbiology, University of Pittsburgh
-
Senior Lecturer, Medical Microbiology, University of Westminster
-
Principal Medical Scientist at National Institute for Communicable Diseases (NICD), National Institute for Communicable Diseases
-
Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
-
Canada Research Chair in Aging & Immunity, McMaster University
-
Professor, Biology, York University, Canada
-
Adjunct Professor: Department Internal Medicine, University of Pretoria
-
Director: SACEMA, South African Centre for Epidemiological Modelling & Analysis (SACEMA)
